BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/25/2017 7:20:44 AM | Browse: 1268 | Download: 1932
 |
Received |
|
2017-01-22 10:44 |
|
Peer-Review Started |
|
2017-01-22 16:26 |
|
To Make the First Decision |
|
2017-03-06 18:02 |
|
Return for Revision |
|
2017-03-08 08:55 |
|
Revised |
|
2017-05-05 23:07 |
|
Second Decision |
|
2017-06-21 00:37 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-07-03 02:46 |
|
Articles in Press |
|
2017-07-03 02:46 |
|
Publication Fee Transferred |
|
2017-07-21 04:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-10-23 08:33 |
|
Publish the Manuscript Online |
|
2017-10-25 07:20 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Thalidomide and thalidomide analogues in treatment of patients with inflammatory bowel disease: Meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Khan Rana Sami Ullah, Yu-Lin Xiong, Ying-Lei Miao, Ummair Saeed and Wei Dai |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wei Dai, Department of Gastroenterology, First Affiliated Hospital of Kunming Medical University, Yunnan Institute of Digestive Disease, 295 Xichang Road, Kunming 650032, Yunnan Province, China. 1499016686@qq.com |
| Key Words |
Inflammatory bowel disease; Thalidomide; Thalidomide analogues; treatment; Efficacy; Safety; Meta-analysis |
| Core Tip |
The aim of this meta-analysis is to examine the efficacy and safety of thalidomide and thalidomide analogues for induction and maintenance of remission in patients with inflammatory bowel disease (IBD). The literature was searched in the databases: PubMed, EMBASE, Ovid and the Cochrane Library, and Chinese databases. The Randomized Controlled Trials was performed during this analysis to assess the effects of thalidomide therapy on IBD patients that did show good response with other therapies. Weighted pooled outcomes were synthesized with a fixed-effects model to account for clinical heterogeneity. This meta-analysis showed that there is not enough evidence to support the use of thalidomide or its analogues in the treatment of IBD for patients of any age. |
| Publish Date |
2017-10-25 07:20 |
| Citation |
Sami Ullah KR, Xiong YL, Dai W, Miao YL, Ummair SU. Thalidomide and thalidomide analogues in treatment of patients with inflammatory bowel disease: Meta-analysis. World J Meta-Analysis 2017; In press |
| URL |
http://www.wjgnet.com/2308-3840/full/v5/i5/124.htm |
| DOI |
http://dx.doi.org/10.13105/wjma.v5.i5.124 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
